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ABSTRACT 
Bimodal Upconverting Nanoparticles for MRI and Optical Imaging  
Qian Ying Li, M.Sc. 
Integrating multiple functionalities into individual nanoscale materials is of tremendous 
importance in biomedicine, since this would expand the capabilities of nanoscale materials to 
perform multiple tasks. Here, fluorescence optical imaging and magnetic resonance imaging 
(MRI) are combined within the same nanoparticle based material. NaYF4: Tm
3+, Yb3+, showed 
NIR to NIR upconversion, giving deep tissue penetration, which is an advantage in medical 
imaging. Their lanthanide ions (Tm3+/Yb3+) derived optical properties in the near infrared region 
of the spectrum, where tissue is maximally transparent. Multimodal properties may be imparted 
to NaYF4: Tm
3+, Yb3+ via the functionalization of gadonium-tetraazacyclododecanetetraacetic 
acid (Gd-DOTA), a commercially available MRI contrast agent. Gd-DOTA was covalently 
bonded to the surface of the silica coated UCNPs using the click reaction. This imaging probe 
may be used for both MRI and fluorescent imaging.  
Another approach to achieve bimodalities is by doping Gd3+ ions into the systems of 
UCNPs, which provides both magnetic and optical properties.  Ultra-small NaGdF4, Tm
3+, Yb3+ 
of 5 nm was chosen since it is an excellent T1 contrast agent. The surface chemistry of 
nanoparticles has direct impact on its physiochemical properties. Therefore, it is aimed to design  
nanoparticle based blood pool contrast agent for disease diagnostics, which involved the 
functionalization the polyethylene glycol (PEG) polymer on the ultra-small UCNPs.  Here we 
report the design and characterization of bimodal contrast agent, PEG coated ultra-small NaGdF4, 
Tm3+, Yb3+.  
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 Chapter One – Introduction 
1.1 Nanotechnology and Nanomedecine 
Nanotechnology has become a rapidly growing area of science over the last decade. It has 
drawn much attention in research and development due to its promising benefits in the fields of 
medicine, electronics, material engineering etc. In the domains of health and medicine, 
nanotechnology has developed quickly and is used extensively in clinical research. Therefore, it 
is important to understand the unique properties of nanomaterials, the benefits and risks of using 
nanomaterials for medicinal purposes.  
Nanoscience may be broadly defined as the study of materials and devices usually less 
than 100 nm. However, this threshold is arbitrary and much discussion has occurred over the 
years as to whether a more lax definition at 1000 nm should be used since many nanoscience 
topics would be left in limbo. Ozin in his seminal book on Nanochemistry states “nanochemistry 
should not be defined only in terms of a length scale”.  He proposes to use concepts such size, 
shape, self-assembly and defects. All of these concepts are important in understanding. For 
example as the particle size decreases to the nano-regime, the surface to volume ratio increases 
imparting very interesting properties to the material since the majority of atoms now lie on the 
surface. Atoms at the surface in general possess dangling bonds which increases the surface 
energy. Since nature likes to reduce the free energy it will reduce the surface energy by causing 
the dangling bonds to react. With such consequence, the surface at the nanoscale show high 
reactivity in comparison to the bulk. Other properties of materials which are size dependent are 
optical, magnetic and electronics [1]. 
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A common example of change in the optical property due to size is the quantum dots 
whereas an excellent example of size shape relationship is found for gold. In the case of quantum 
dots, their unique optical properties arise from their physical dimensions, which are smaller than 
the “exciton Bohr radius” that ranges roughly between 2 and 20 nm. An excited electron in solids 
“roams” around the “parent” atom at a distance equal to the “exciton Bohr radius”. If the 
physical size of the nanoparticle becomes comparable or smaller than the “exciton Bohr radius” 
the electrons start to behave differently affecting the electron structure thus the optical properties. 
The color of gold at the nanoscale is determined by the oscillating frequency of the conduction 
electrons. These oscillations are known as “plasmons” [2]. Spherical gold nanoparticles are 
isotropic therefore the conduction electrons have a single frequency of oscillation. However if 
the gold nanoparticle is rod shape (anisotropic) two different frequencies of oscillation, 
transverse and longitudinal thus the colour of the gold nanorods will be different. 
Nanomaterials are expected to have a major impact on nanomedicine since the nanometer 
scale is interesting in biological systems (for example proteins are tens of nanometer in size) 
since it would allow to probe biological systems. Nanomaterials have been proposed for a 
number of uses including imaging, diagnostics and therapeutics. The major interest in 
nanoparticles stems from optical and magnetic properties, which may be used in imaging both in 
vitro and in vivo.  
At the tissue level, the enhanced permeability and retention (EPR) effect is the size 
dependent property which is very important in tumor targeting [3].  A key benefit offered by 
nanomaterials is the possibility to achieve “active” targeting making use of the reactive surface 
which would facilitate functionalization of the nanoparticles [4]. However, much more work is 
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needed to characterize the full impact of size, shape, surface chemistry, the EPR effect, cell 
targeting etc. of nanomaterials in  biological systems.  
1.2 Lanthanide-Doped Nanoparticles (LnNPs) in Potential Biological Applications 
Nanocrystals of rare-earth compounds, such as oxides [5], phosphates [6], fluorides [7] 
have recently become a new focus of research due to their unique optical property, and have 
become promising candidates for fluorescence labeling [8]. The unique feature of these 
nanoparticles is their ability of emitting photons in visible range following near infrared 
excitation, in a process called upconversion. β-NaYF4 is considered to be among the most 
efficient host material for upconversion phosphors, when co-doped with Yb3+ and Er3+ or Tm3+ 
ions. More interestingly, doping with highly paramagnetic Gd3+ ions has demonstrated the 
potential use as a T1 contrast agent in magnetic resonance imaging [9]. 
 
1.2.1 In vitro Optical Imaging 
There are substantial advantages that lanthanide-doped nanoparticles offer in the 
biomedical applications. For example, in the application of in vitro cell and tissue imaging, 
Zijlmans et al. [10] in 1999 used Y2O2S:Tm/Yb to study the distribution of prostate specific 
antigent (PSA) in paraffin-embedded sections of human prostate tissue. They provided two 
important evidences of using lanthanide doped nanocrystals as fluorescent probes over 
conventional ones. The problem of non-specific autofluorescence associated with UV excitation 
was absent under near infrared (NIR) excitation which resulting in a low optical background 
autofluorescence since biomolecules show minimal absorbance in the NIR region 700-1000 nm 
(optical window). Moreover, it was reported that lanthanide doped upconverting nanoparticles 
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(Ln-UCNPs) did not show photobleaching due to unaffected chemical bonds in the photo cycle 
and demonstrated excellent sensitivity. Thus, it demonstrated for the first time the potential 
application of Ln-UCNPs as luminescent probe for bioimaging.  
 
1.2.2 In vivo Optical Imaging 
Organic fluorophores and fluorescent proteins have been traditionally used for in vivo 
optical imaging which require UV excitation. Not only they suffer from low photostability and 
strong background autofluorescence, the resulting broad bands often cause spectral overlap 
which could be a problem in spectral interpretation during multicolor imaging. Quantum dots 
(QD) are one of most extensively-studied luminescence nanoparticles.  The use of QDs in vivo 
studies raises few problems related to the its toxicity due to the use of heavy metals and potential 
tissue damage caused by the use of ultraviolet excitation (UV) [11].  
In contrast to organic fluorophores, Ln-UCNPs are characterized with high photostability, 
no photobleaching, and narrow photoluminescence spectra which make them suitable for 
multiplexed imaging [12].  In contrast to QD, Ln-UCNPs have low cytotoxicity, no 
photoblinking and the color of the emitted light does not dependent on the size of luminescent 
nanoparticles, but only on the nature of the lanthanide ions, and thus avoiding the need to 
separate particles of different sizes formed during the synthesis [13, 14].  
Moreover, the challenge faced for in vivo optical imaging is tissue penetration depth due 
to light scattering. Light scattering is dependent on the inverse of the excitation wavelength 
(Rayleigh scattering), therefore, Ln-UCNPs which use low energy near infrared (NIR) as 
excitation source, offer a greater tissues penetration depth in comparison to its UV counterparts. 
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In vivo imaging of LnNPs was reported by Zhang and co-workers [15] using 50-nm NaYF4: Er, 
Yb nanoparticle in rats. Following 980 nm excitation, the characteristic visible green emission of 
Er3+ was detected up to 10 mm beneath the skin. The suitability of Ln-UCNPs for in vivo optical 
imaging was also demonstrated by Nyk et al. [16] using NaYF4: Tm, Yb.  The remarkable 
advantage of using thulium is NIR-to-NIR upconversion, offering greater tissue penetration since 
both the excitation and emission wavelength fall within the optimal optical window. The whole 
body image showed high contrast and high signal-to-ratio, which demonstrated the excellent 
potential of Ln-UCNPs for in vivo imaging.  
 
1.3 Magnetic Resonance Imaging (MRI) 
The interesting optical properties of Ln-UCNPs have been demonstrated in biological 
systems. Doping these nanoparticles with Gd3+ ions would provide an additional imaging 
modality since the Ln-UCNPs would be used in magnetic resonance imaging.  
Among all of the currently used diagnostic tools, MRI is one of the most powerful 
imaging techniques, which provides a high resolution image non-invasively. MRI provides 
functional and anatomical details of human body, allowing clinical professionals to distinguish 
normal and diseased tissues. Gadolinium (Gd3+) is an extensively studied paramagnetic agent 
which shortens the T1 relaxation times of protons, resulting in better contrast resolution, and 
improving the visibility of internal structures for clinical practices. Several Gd3+ based chelates 
are commercially available such as Dotarem, Omniscan and Gadovist. These Gd3+ chelates have 
rather low relaxivity, and must be administered in quite high dose to provide a good contrast [17] 
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In recent years, increasing research activities have been focused on nanoscaled contrast 
agents materials for MRI, for example, the doping of Gd3+ ions oxides or fluorides nanoparticles 
[18, 19]. The main advantage of using nanoparticles based systems compared to chelate 
complexes is that the former is expected to yield higher relaxivities due to a higher concentration 
of magnetic ions, thus increasing the sensitivity of the technique. In addition, the benefit of 
having Gd3+ ions into the crystal system would reduce substantially the leakage of Gd3+ ions to 
the body which is a concern when using the Gd3+ complexes. Another advantage of the Gd3+ 
doped nanoparticles contrast agent for MRI is that it would have longer circulation time due to 
enhanced vascular permeability thus an excellent agent for medical imaging [20, 21]. 
Nanoparticles also offer the added advantage that is the surface can be functionalized imparting 
active targeting properties.  
 
1.4 Objectives  
Among all the imaging techniques, optical imaging is well-known for its high sensitivity, 
and capable of providing cellular- or molecular-level information. However, it still lacks the 
capability to obtain full anatomical and physiological structures.  On the other hand, MRI 
provides excellent spatial resolution and penetration depth for in vivo imaging, and provides 
exceptional anatomical information, but suffers from limited sensitivity and lacks resolution for 
imaging at the cellular level. The combination of MRI and optical imaging leads to the 
development of new approaches to bridge the gap of high sensitivity and high spatial resolution 
and offset the drawbacks of these two modalities. For example, a combination of in vivo imaging 
could be used to image a tumor pre-operatively utilizing MRI and intraoperatively using optical 
imaging which could facilitate the image guided real time surgery.  
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Therefore, the objective of this thesis is to design a hybrid magnetic and optical imaging 
probe. Due to the potential benefits of nanoscaled materials for in vivo imaging, lanthanide 
doped nanoparticles are selected as the base material for engineering a biocompatible bimodal 
contrast agent. There could be two approaches for designing such nanoconstruct. First, the 
paramagnetic property could be added to the upconverting nanoparticles by surface 
functionalization; Secondly, gadolinium could be incorporated into the host material such as 
NaGdF4: Tm
3+, Yb3+, which has both optical and magnetic properties. Moreover, Tm3+ ion has a 
characteristic strong emission centered at 800 nm following 980 nm excitation. NIR emission has 
significant advantage over visible emissions for in vivo imaging.  
The ideal nanoparticle contrast agent for biological applications should fullfill a number 
of stringent requirements: it should be water dispersible; stable in biological conditions (i.e resist 
aggregation); it should exhibit minimum nonspecific binding and be resistant to 
reticuloendothelial system (RES) or macrophage system uptake, it should provide a good 
contrast quality (high signal-to-noise ratio) and sufficiently long circulation times in the blood if 
administrated intravenously [22].   
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 Chapter Two – Theory 
2.1 The Lanthanides 
The lanthanides comprise the largest naturally-occurring group in the periodic table. The 
lanthanides are the group of elements occupying the sixth row of the periodic table starting from 
element 51 (lanthanum) to 71 (lutetium). While scandium and yttrium are not part of the 
lanthanide series, they are usually considered lanthanide-like or "lanthanoides" due to the 
similarity in their chemical properties and their occurrence in the same ores as the other elements 
of the lanthanides. 
While some of the lanthanides may exist in the +2 and +4 oxidation states, the +3 
oxidation state is the most prevalent and is generally known to be the most stable configuration 
for the lanthanide ions. This stems from the fact that the +3 oxidation state leaves the ions in the 
[Xe] 4f x configuration and the ionization energy of the f electrons is so large, that they are 
considered core-like. This measure of stability also implies that modification via chemical means 
is highly difficult.  
The ionic radii of the lanthanides decrease from 103 pm (La3+) to 86 pm (Lu3+) shown in 
figure 2.1. The poor nuclear charge shielding behavior of the f electrons occurs due to the fact 
that the 6s and 5d electrons are drawn closer towards the nucleus resulting in the well-known 
lanthanide contraction effect. The f-electrons are the poorest with respect to shielding, while the 
s-electrons are the best. The 5s2 and 5p6 electrons penetrate the f-subshell and as the nuclear 
charge increases, an increase in the contraction is also observed. The shielding of the f-electrons 
by their s and p counterparts has a direct impact on the magnetic and spectroscopic properties 
especially in the fact that they are highly uninfluenced by the ligands coordinating the lanthanide 
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atoms. In addition, the crystal field splitting is significantly less in comparison to that of the d-
block elements. As a result, the bands in the electronic spectra of the lanthanides are very sharp 
showing narrow emission profiles. Additionally, f-f transitions are Laporte forbidden, resulting 
in low transition probabilities and long excited states lifetime (on the order of ms). The 
lanthanide elements have ladder-like energy levels of 4f states which allow for sequentially 
absorption of multiple photons with suitable energy to reach a higher excited state, giving rise to 
an important property of lanthanides ions: upconversion. [23, 24, 25, 26] 
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2.2 Upconversion Mechanisms 
Upconversion (UC) refers to the generation of light with wavelength shorter than the 
excitation source.  There are three major mechanisms by which upconversion may occur namely 
excited state absorption (ESA), energy transfer upconversion (ETU) and photon avalanche (PA) 
upconversion. However, for the purpose of this thesis we will only discuss excited state 
absorption and energy transfer upconversion.  
Excited state absorption involves the sequential absorption of two or more long 
wavelength photons promoting an ion from the ground to an excited state and followed by the 
emission of one higher energy photon (shorter wavelength). Figure 2.2 (a) showed the ESA 
mechanism. The ion in the ground state absorbs a pump photon ① and is excited to an 
intermediate excited state E1. A second pump photon ② promotes the ion to a higher excited 
state E2 followed by emission and relaxation of the ion to the ground state.  
Energy transfer upconversion occurs via the transfer of energy between a neighbouring 
pair of ions where one ion acts as a donor of energy, while the second acts as an acceptor of 
energy. A simplified mechanism of energy transfer upconversion is summarized in 2.2 (b). In 
this upconversion process, an incoming pump photon, corresponding to the energy gap 
separating states G and E1, promotes both donor ions (usually an ion with a high absorption 
cross-section) to the intermediate excited state E1 (step ). In the second step (), a non-
radiative energy transfer from the donor ion to the acceptor ion results in the promotion of the 
latter to its excited state E1 after which a second energy transfer promotes the acceptor ion to 
excited state E2 (). Following the energy transfer, the donor ions relax to their ground state 
while the acceptor ion, now in E2, undergoes a radiative decay with emission and returns to its 
ground state. The ETU mechanism is dependent on the overall dopant ion concentration due to 
   11 
the increased proximity of neighboring ion pairs that facilitate the energy transfer process. 
Furthermore, the mechanism efficiency is also influenced by the choice of donor and acceptor 
ions, as well as their respective concentrations [26]. 
 
Figure 2.2: Upconversion mechanisms (a) excited-state absorption (ESA); (b) energy transfer 
upconversion (ETU). 
   12 
2.3 Upconversion Materials: Lanthanide-Doped Nanoparticles 
2.3.1 Host Materials 
The inorganic host crystal plays an important role in the efficiency of the upconversion 
processes. An ideal host for UC process to occur needs to possess high chemical stability, low 
lattice phonon energies that minimize non-radiative process and maximize radiative emissions 
and close lattice matches to the dopant ions. To the date, upconversion process have been studied 
in nano sized host matrices such as fluorides (NaYF4, NaYbF4, NaGdF4, NaLaF4, LaF3), 
oxyfluorides (GdOF), oxides (La2O3, Lu2O3, Y2O3), halides (BaCl2, CsCdBr3, Cs3Y2I9), 
oxysulfides (Y2O2S), phosphates (YPO4) and vanadates (YVO4). Halide hosts such as chlorides, 
bromides, and iodides normally exhibit low phonon energies (< 300 cm-1) however, they are 
hygroscopic. Oxide hosts have relatively high phonon energies, generally higher than 500 cm-1. 
Fluoride host is the most desirable host with high chemical stability and low phonon energies 
(~350 cm-1) [28]. 
It is also known that the crystal structure of the host material significant influences 
upconversion efficiency. It has been observed that the crystalline host of hexagonal phase of   
NaGdF4 or β-NaYF4 exhibit higher upconversion efficiency relative to cubic counterparts [29]. 
This dependency is attributed to the different crystal fields around the Ln3+ in both crystal phases. 
Low symmetry hosts offer more uneven components around Ln3+ enhancing the electronic 
coupling between 4f energy levels and higher electronic configuration that subsequently 
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2.3.2 Lanthanide Dopant Ions 
It is well established that lanthanide ions exhibit low absorption cross-sections with the 
consequence that they demonstrate low pump efficiency. Thus, the upconversion efficiency is 
low for single doped nanocrystals. In order to enhance the upconversion efficiency, co-doping of 
the host is used with two different lanthanide ions. One of the dopant ion acts as the activator and 
the other usually is Yb3+ as the sensitizer. It has been shown that this approach will favor a more 
efficient ETU mechanism.  
Yb3+, with an absorption band located at 980 nm, and a large absorption cross section in 
comparison to other lanthanide ions. The energy associated with the 2F7/2  2F5/2 transition is 
resonant with the most commonly used activators Er3+ and Tm3+. In Figure 2.3, the visible and 
NIR emissions, which are obtained via the ETU process where Yb3+ is the sensitizer and Er3+ and 
Tm3+ as activators. It has been found that the best upconversion efficiency occurs when the 
sensitizer concentration is approximately 20 mol% and the concentration of the activator 0.5=2 
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Figure 2.3: Partial energy diagram for the three trivalent lanthanide ions adopted from the “Dieke 
diagram” [28]. 
 
2.4 Magnetic Resonance Imaging (MRI) 
In this section, the basic physical concepts of MR imaging will be summarized, and only 
the in vivo imaging on the basis of proton spin will be considered. The human body consist of 
approximately 63% protons (table 2.1), which includes both water and macromolecules [31]. 
Moreover, the high amount of water and the interaction of water with other macromolecules that 
determines the relaxation properties, allow the construction of an anatomical image for 
diagnostics purposes.  
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Table 2.1: Essential chemical elements composition in the body. 
 
 
2.4.1 Proton Nuclei and their Behaviour in the Magnetic Field 
MRI is based on the basic principles of nuclear magnetic resonance (NMR). The basic 
concept of MRI involves the interaction of the hydrogen proton spins with an applied magnetic 
field. In the absence of an applied magnetic field, all the spin states of a given nucleus are 
degenerate. Each proton has its own magnetic field and their magnetic fields are oriented 
randomly. This random orientation results in a net magnetization of zero.  Application of an 
external magnetic field results in the alignment of the proton spins either parallel or anti parallel 
to the magnetic field. However, over time the proton spins will align more in the parallel 
direction, which is the lower energy configuration (figure 2.4). Once equilibrium is achieved, the 
small net excess of the proton spins in the parallel direction gives a net magnetization in the 
direction of the external field [32]. 
 
Figure 2.4: Behaviour of proton spins in a static external magnetic field. 
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2.4.2 Interaction with a Radiofrequency Field  
Suppose equilibrium is disturbed such that it no longer lies along the z axis, precession 
motion will occur during the process as the spinning nuclei return to their natural equilibrium 
state (figure 2.5). The precession frequency ωo, usually referred to as resonance frequency is 
directly proportional to the external applied field. Once equilibrium is achieved, the net 
magnetization is aligned along the direction of the external field and therefore does not precess.  
The precession motion becomes more obvious when the second external field B1, 
perpendicular to the Bo  is applied. Additionally, B1 rotates clockwise at frequency ωo.  If the field 
is applied for a short period of time, the net magnetization will be now precess slowly from the 
vertical axis (around Bo field) toward the B1 field. This is an important concept in nuclear 
magnetic resonance where the absorption of energy by the nuclei resulting in the change of their 
spin orientation. Proton nuclei absorb radiation frequency of 60.0 MHz at a magnetic field 
strength of 1.41 Tesla, which is generally used in clinical MR imaging [33]. 
 
Figure 2.5: A collection of protons precess around the axis of an external field. A small excess if 
protons aligned with the field to produce a net magnetization (Mz) along the external field 
direction [33]. 
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2.4.3 Relaxations 
When a given population of nuclear spins aligned with a static magnetic field Bo is 
excited with an electromagnetic field B1, perpendicular to Bo with a frequency equal to the 
precession frequency, also referred to as Larmor frequency, this causes the absorption of energy 
by the nuclear spins. From this perturbed state, the system relaxes back to its equilibrium state, 
which is the alignment of net magnetization (Mz) with the external field direction again. This 
process of relaxation is the observed NMR signal.  
Therefore, in order to have NMR signal, the bulk magnetization Mz needs to be tilted 
away from the z-axis by the radiofrequency pulse (B1). The tilt θ is proportional to the field 
strength of the pulse (B1) and the time it was applied. Since the radiofrequency pulse tilts the 
vector Mo away from the vertical axis, the vector now has components Mx, My, Mz, tilted angle θ 
along with z axis and the angle φ lying in the xy-plane (figure 2.6). Since the angle φ is only 
dependent on the Larmor frequency, xyz systems is changed to x’y’z for the simplicity of 
mathematical expression of the relaxation, in which x’ and y’ axes rotate with the Larmor 
frequency. 
 
Figure 2.6: The vector Mo and its components Mx, My, and Mz [34]. 
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During relaxation, the bulk magnetization Mo will gradually return to its equilibrium state, 
in which Mx’ and My’ will return to their initial zero values and Mz will be equal to Mo. This 
relaxation is first described by Bloch in 1946 and the equations below are now known as the 
Bloch equations [35]. 
  
                         
 
2.4.3.1 Longitudinal Relaxation  
   The magnetization along the z axis is referred to as longitudinal magnetization (Mz) and 
the one perpendicular to this direction (in the xy-plane) is referred to as transverse magnetization 
(Mxy). Following a 90° radiofrequency (RF) pulse, Mz is converted is into Mxy. T1 relaxation or 
longitudinal relaxation is the process where the system returns to equilibrium once the RF pulse 
is turned off. T1 is called the spin-lattice time constant and characterizes the return to equilibrium 
along the z-direction (direction of Bo field). T1 relaxation involves the exchange of thermal 
energy between the nuclei and the surrounding lattice. The recovery for longitudinal 
magnetization occurs in an exponential fashion (Equation 2.3) [33]. 
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2.4.3.2 Transverse Relaxation  
Following a 90o radiofrequency (RF) pulse, the system eventually returns to its 
equilibrium. As there is a gradual gain of magnetization along the z direction, there is a decay 
magnetization in the transverse plane simultaneously. Therefore, the same factors accounts for T1 
relaxation also account for T2 relaxation. The decay of traverse magnetization (Mxy) is referred to 
as T2 relaxation or transverse relaxation. However, T2 relaxation also depends on other factors 
such as homogeneity of the external field and spin spin interaction which cause dephasing of the 
vector. Therefore, T2 ≤ T1. Shown in figure 2.7, after 90o RF pulse, the precessing nuclear spins 
will gradually lose their coherence and fan out. The observed relaxation time due to the 
inhomogeneity of the magnetic field Bo and spin spin relaxation is expressed by T2* in equation 
2.4 [33].  
 
Figure 2.7: (a) Mz is converted to Mxy following 90°
 RF pulse; (b) and (c) gradual dephasing of 
Mzy vector [34]. 
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2.4.4 Gadolinium as a Contrast Agent 
The trivalent lanthanide ion (Gd3+) contains the highest possible number of unpaired 
electrons (seven), which makes it the most paramagnetic among the stable metal ions. It 
functions to increases the relaxation rate of proton due to its paramagnetic property, and thus, 
enhancing the contrast of MR images. The clinical gadolinium based contrast agents are 
introduced into the body as a chelate form, through intravenous injection.  
 
2.4.4.1 Relaxivity 
The observed Ti (i=1, 2) of an aqueous solution containing a contrast agent can be written 
as consisting of a diamagnetic and paramagnetic contribution in the absence and presence of a 
contrast agent respectively (equation 2.5). 
 
The paramagnetic contribution on the relaxation rate is directly proportional to the 
concentration of the contrast agent. If the concentration of Gd3+ is given in mM, the parameter r1 
is defined as proton relaxivity and can be determined from the slope of the equation 2.6, where c 
is the concentration of the contrast agent (equation 2.6). Relaxivity is normally expressed in mM-
1 s-1.  The relaxivity value directly refers to efficiency of the contrast agent in the enhancement of 
relaxation rate of water protons [36]. 
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2.4.4.2 Paramagnetic Relaxation of the Water Protons 
Free Gd3+ ions are not effective in affecting the relaxation of water molecules due to the 
rapid rotation of the small ions. Attaching Gd3+ ion to molecules such as diethylene triamine 
pentaacetic acid (DTPA) has the effect of slowing down the tumbling rate of the system, at a rate 
closer to the resonance frequency of water protons. The paramagnetic relaxation of water arises 
from dipole-dipole interactions between the protons nuclear spins and the fluctuating local 
magnetic field caused by the unpaired electron spins of the paramagnetic substance [33]. 
The effect caused by a contrast agent on the surrounding water molecules depends on the 
distance between the paramagnetic ion and the protons of the water molecules. The major 
contribution of the overall paramagnetic relaxation is from the inner-sphere water molecules, 
which directly bound to the paramagnetic ion. The proton relaxivity results from the interaction 
of Gd3+ electron spins and the water protons in the first coordination sphere via exchange of 
water molecules with the bulk solvent (figure 2.8). The paramagnetic center could also affect 
water molecules hydrogen bonded to the ligand (usually to its carboxylate or phosphonate 
groups). The contribution of the second sphere protons to the relaxation rate are however 
negligible in many cases [36, 37]. 
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Figure 2.8: Inner-sphere, 2nd sphere and bulk water, τ R: rotational correlation time, kex: 
water/proton exchange rate [37]. 
 
 The development of gadolinium based contrast agent mainly involves in enhancing the 
proton relaxivity from the inner-sphere which depends on a large number of parameters. To 
name a few:  
- proton exchange rate, Kex = 1/ τm (τm is the life time of a solvent water molecules in  the 
inner sphere of the complex) 
- rotational correlation time, τR  
- hydration number q (number of water molecules coordinated to the Gd3+ center) 
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 Rotation is perhaps the most critical parameter in the optimization of proton relaxivity at 
a given field strength. Experiment has been shown that by decreasing the τR from 1 ns to 0.1 ns, 
it has effect of increasing the bound relaxation rate (1/T). Moreover, the relaxation enhancement 
will approach a maximum as the inverse of the overall correlation time (in consideration of the 
rotational frequency, proton exchange rate and the relaxation rate) approaches the Larmor 
precessional frequency [37].   
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 Chapter Three: Experimental and Characterization Techniques 
3.1 Thermal Decomposition Synthesis of Upconverting Nanoparticles NaYF4: Tm3+/Yb3+  
The NaYF4:Tm
3+ (0.5%)/Yb3+ (25%) upconverting nanoparticles were synthesized via the 
thermal decomposition method established by our group [7]. Two major steps were involved in 
the synthesis: (1) preparation of the trifluroacetate lanthanide precursors, (2) synthesis of the 
oleate capped nanoparticles. 
 
3.1.1 Procedure for the Preparation of Precursor: Lanthanides Trifluoacetate Salts   
0.5 mol % of Tm2O3(0.0024 g), 25 mol% of Yb2O3 (0.1232 g) and 74.5 mol % of Y2O3 
(0.2103 g) were added to a 50 mL round bottom flask. The addition of 10 mL (1:1) mixture of 
water/trifluoroacetic acid gave a white solution, which was refluxed at 80 ℃ for 12 hours until 
the solution turns clear. The solvents were evaporated at 60 ℃ and the products were brought to 
dryness.  
 
3.1.2 Procedure for the Synthesis of Upconverting Nanoparticles NaYF4: Tm3+/Yb3+ 
The precursor prepared in previous step were stored in an oven of 60 ℃  prior the 
synthesis of nanoparticles. To synthesize the nanoparticles NaYF4: Tm
3+/Yb3+, 25 mL (1:1) 
mixture of oleic acid and 1-octadecene was added to a 100 mL three-neck round bottom flask, 
referred as reaction flask. Under vacuum, the solution was stirred and degassed at 150 ℃ for 30 
minute. The solution was purged using argon and the temperature was maintained at 150 ℃. 
After 15 minutes, the temperature was raised to 310 ℃. 
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To the 50 mL round bottom flask containing lanthanides trifluoacetate precursor, 15 mL 
of (1:1) mixture of oleic acid and 1-octadecene was added.  The mixture was stirred and 
degassed at 45 ℃, 75 ℃ and 125 ℃ for 5 minutes respectively. Then, the precursor solution was 
injected into the reaction flask using a syringe and pump system at rate of 0.75 mL/min at 310 
℃ . As soon as the injection was completed, the mixture was left to react for one hour, at 310 ℃, 
under a gentle flow of argon. The nanoparticles were collected via precipitation using ethanol 
and washed with mixture of hexane and ethanol (1:7) few times [7]. 
 
3.2 Procedure Optimization for the Synthesis of NaYF4: Tm3+/Yb3+ in Thermal 
Decomposition Method  
In order to obtain monodisperse NaYF4: Tm
3+/Yb3+, an optimization of the procedure was 
carried out.  Shown in the table 3.1, the parameter varied was the injection rate while the 
temperature and reaction were kept constant.  
 
Table 3.1: Variation of parameters in thermal decomposition method. 
Temperature Injection Rate (mL/min.) Reaction time (min) 
310 ℃ 1.0 60 
310 ℃ 0.75 60 
310 ℃ 0.30 60 
 
 
3.3 Synthesis Procedure of Ultra-small NaGdF4: Tm3+/Yb3+   
 In a 100 mL three-neck round bottomed flask, 0.745 mmol of GdCl3 · 6H2O (0.2769 g), 
0.005 mmol of TmCl3 · 6H2O (0.0019 g), 0.25 mmol of YbCl3 · 6H2O (0.0969 g), 4 mL of oleic 
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acid and 15 mL of 1-octadecene were added. Under vacuum, the solvents were stirred and 
degassed for 5 minutes at room temperature, and raised up to 150 ℃ and maintained at this 
temperature for 30 minutes. The mixture was then cooled to room temperature. A 10 mL of 
methanolic solution of NH4F (4 mmol, 0.1500g) and NaOH (4 mmol, 0.1000 g) was injected 
using a syringe and pump system at a rate of 0.35 mL/min (Harward Apparatue Econoflow). The 
solution was let stirred at room temperature for 24 hours. Finally, the solution was slowly heated 
at 265 ℃ for 30 min. under argon. The nanoparticles were collected via precipitation using 
ethanol and washed with mixture of hexane and ethanol (1:7) few times [38]. 
 
3.4 Procedures for Surface Modifications of Nanoparticles towards Water Dispersibility 
and Multimodalities 
In order to render the oleate capped upconverting nanoparticles water dispersible. Two 
approaches were employed: silica coating and polymer coating.  
3.4.1 Silica Coating  
3.4.1.1 Silica Coating Procedure for Nanoparticles of Size approximately 20 nm 
In a glass vial, 40 mg of wet oleate capped nanoparticles and approximately 1 g of 
surfactant Igepal CO-520 were dispersed in 12 mL of cyclohexane by sonication for 15 min. 
While the mixture was stirring, 100 μL of ammonium hydroxide (28.0 – 30.0 % NH3 basis) was 
added dropwise. The solution was let stirred for 30 min. Finally, 75 μL tetraethyl orthosilicate 
(TEOS) was added dropwise into the solution, and the reaction was continued for another 48 
hours. The silica coated upconverting nanoparticles were precipitated using acetone and 
collected by centrifugation. The nanoparticles were washed with ethanol several times. The 
nanoparticles were kept wet to be used in the future experiments of surface modifications.   
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3.4.1.2 One Pot Synthesis Procedure of Azide Functional Silica Coated UCNPs 
In order to functionalize the silica nanoparticles with the azide functional silane, same 
procedure used for the silica coating described in section 3.3.1.1 was followed. However, after 
24 hours of reaction, and without precipitating the nanoparticles, 30 μL of 3-
azidopropyltriethoxysilane (AzPTES) was added to the reaction vial. The solution was stirred for 
another 24 hours. The final nanoparticles were precipitated using acetone, centrifuged and 
washed with ethanol. The nanoparticles were kept wet to be used in the future experiments of 
surface modifications.   
 
3.4.1.3 The Click Reaction: Covalent Conjugation of Alkyne-(Gd-DOTA) to Silica Coated 
UCNPs  
10 mg of azide modified silica coated UCNPs and 150 μL of aqueous alkyne_(Gd-DOTA) 
(0.018 mmol) were mixed and dispersed in 2 mL of Millipore water and sonicated for 15 min. 
Under stirring, 54 μL of aqueous sodium ascorbate solution (0.0018 mmol) was added dropwise. 
The mixture was stirred for 5 minutes prior the slow addition of 9 μL of aqueous copper sulfate 
(0.0091 mmol). The color of the solution changed slowly from light blue to light yellowish. The 
mixture continuously stirred for 24 hours and the modified nanoparticles were precipitated with 
acetone and washed with Millipore water [39]. 
 
3.4.2 Polymer Coating Approach: Procedure for Polymer Coating of Ultra-small 
Upconverting Nanoparticles (US-UCNPs) 
5mg of oleate capped, US-UCNPs and 1 mL of 0.2 M PEG diacid (pH = 3) were added 
into a 1.5mL-eppendorf tube. The sample was placed in a thermomixer and was shaked at 300 
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rpm and 40 ℃ for one hour. 0.5 mL of hexane was added to the aqueous solution to form an 
organic/aqueous phase. The resulting mixture was shaken for 30 additional min. The organic 
layer was removed and discarded. The unbound polymer was removed via dialysis.  
 
3.5 Synthesis Procedure for Alkyne Gd-DOTA [41, 42, 43] 
 
3.5.1 Synthesis of 2-bromo-N-(propargyl)acetamide (1) 
 
 
                                             (1) 
 
Dry dichloromethane (150 mL) and bromoacetyl chloride (4.5 mL, 54 mmol) were added to 
a 500 mL oven dried round bottom flask. Under a nitrogen atmosphere and at 0℃ (cooled using 
an ice bath), a solution of propargyl amine (3.7 mL, 54 mmol) and DIPEA (9.6 mL, 54 mmol) in 
dry dichloromethane was added dropwise via a cannula. Once the addition was complete, the 
solution was allowed to warm to room temperature and stirred for 45 min. The reaction mixture 
was concentrated in vacuo. The crude product was purified by column chromatography (silica 
gel, 1:1 of ethyl acetate and hexane).  
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3.5.2 Synthesis of tri-tert-butyl 2, 2̍, 2̍ ̍ - (1,4,7,10-tetraazacyclododecane-1,4,7-triyl) 
triacetate (2) 
                                             (2) 
Compound 2 synthesized using the following procedure. In a 100 mL flask, 1 g (5.8 mmol) 
of 1,4,7,10-tetraazacyclododecane was dissolved in 50 mL of dry CH3CN (HPLC grade) 
followed by an addition of 1.61 g (19.1 mmol) NaHCO3 . A solution of 3 mL (20.3 mmol) t-
butylbromoacetate (98%) in 5 mL of CH3CN was added dropwise to the suspension and the 
mixture was stirred at room temperature for 12 h. The reaction was carried out under an argon 
atmosphere. The residue was filtered through a pad of Celite and the filtrate was evaporated to 
dryness. The residual solid was treated with excess diethyl ether to precipitate the product, 
which was then isolated by filtration.    
 
3.5.3 Synthesis of tri-tert-butyl 2, 2̍, 2̍ ̍ - {10-[2-oxo-2-(2-propyn-1-ylamino)ethyl]-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)} triacetate (3) 
                                                    (3) 
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Compound 3 synthesized using the following procedure. Compound 2 (0.100 g, 0.194 
mmol), compound 1 (0.026 g, 0.194 mmol) and K2CO3 (0.028 g, 0.194 mmol) were added to 100 
mL of CH3CN in a 250 mL flask containing. The mixture was heated under reflux for 12 h. The 
suspension was filtered through a pad of Celite and the solvent was removed in vacuo. The 
product was purified by column chromatography (alumina, 98:2 DCM/MeOH) yielding a white 
solid (Compound 3).  
 
3.5.4 Synthesis of 2, 2̍, 2̍ ̍ - {10-[2-oxo-2-(2-propyn-1-ylamino)ethyl]-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)} triacetic acid (4) 
                                                                  (4) 
Compound 4 synthesized using the following procedure. Compound 3 was dissolved in 
30 mL (1:1) mixture of CH2Cl2 and trifluoroacetic acid (TFA). The solution was stirred for 12 h 
at room temperature. The reaction flask was placed in the warm oil bath and the solvents were let 
evaporated slowly. The residue was suspended in 20 mL of methanol, and solvent were removed 
in vacuo to remove the traces of TFA. This step was repeated two more times with methanol, and 
then three times with CH2Cl2. The final evaporation of solvent yielded a golden oil (compound 
4).  
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3.5.5 Synthesis of gadolinium 2, 2̍, 2̍ ̍ -{10-[2-oxo-2-(2-propyn-1-ylamino)ethyl]-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)}triacetate (5) 
                                                           (5) 
Compound 5 synthesized using the following procedure.100 mg (0.226 mmol) of 
compound 5 and 89.2 mg (0.240 mmol) of GdCl3·H2O were dissolved in 5 mL of deionized 
water, and the pH was adjusted to 6 with 0.1 M KOH solution. The solution was stirred at 60 ℃ 
for 12 h. The solution was treated with CHELEX-100® three times, and the solvent was 
removed in vacuo. The resulting oil was dissolved in minimal volume of methanol. The addition 
of excess of diethyl ether yields a white solid. Chromatographic purification (HPLC) yielded the 
corresponding Gd(III) complex (compound 5).  
 
3.6 Characterizations Techniques 
3.6.1 Fourier Transform Infrared (FTIR) Spectroscopy 
The FTIR spectra presented in this thesis were measured using a Nicolet 6700 FTIR 
spectrometer. KBr were prepared as the background. 
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3.6.2 Transmission Electron Microscopy (TEM) 
TEM analysis was performed using a Philips CM200 microscope operating at 200 kV 
equipped with a charge-coupled device (CCD) camera (Gatan). Prior to analysis, the 
nanoparticles were dispersed in toluene to yield a 0.5 wt% solution. A few drops of the resulting 
solution were evaporated on a formvar/carbon film supported on a 300 mesh copper grid (3 mm 
in diameter). 
 
3.6.3 X-Ray Powder Diffraction (XRPD) 
XRPD patterns were measured using a Scintag XDS-2000 Diffractometer equipped with a 
Si(Li) Peltier-cooled solid state detector, a Cu Kα source using a generator power of 45 kV and 
40 mA, divergent beams (2 mm and 4 mm), and receiving beam slits (0.5 mm and 0.2 mm). The 
scan range was set from 10-90° 2θ with a step size of 0.02° and a count time of 2 s. All samples 
were measured using a quartz “zero background” disk. 
 
3.6.4 Upconversion Luminescence Spectroscopy 
The luminescent emission properties of the lanthanide-doped nanoparticles were 
measured following 980 nm excitation using a Coherent 6-pin fiber-coupled F6 series (core) 
fiber. For the spectroscopic studies, the sample was dispersed in toluene (1 wt%) and placed in a 
Hellma, QS quartz cuvette (1 cm path length). The upconverted visible emission were collected 
at 90 degrees with respect to the incident beam and then dispersed by a 1 m Jarrell-Ash Czerny-
Turner double monochromator with an optical resolution of ~0.15 nm. The visible emissions 
from the sample exiting the monochromator were detected by a thermoelectrically cooled 
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Hamamatsu R943-02 photomultiplier tube. A preamplifier, model SR440 Standard Research 
Systems, processed the photo-multiplied signals and a gated photon counter model SR400 
Standard Research Systems data acquisition system was used as an interface between the 
computer and the spectroscopic hardware.  
 
3.6.5 Mass Spectrometry 
Mass spectrometry measurements were performed using a LC-MSD TOF (Agilent) with 
ESI as the ionisation source and in the mass range of 100–2000 m/z.  
 
3.6.6 X-Ray Photoelectron Spectroscopy (XPS) 
The XPS analysis of PEG and lysine grafted ultra-small NaGdF4: Tm
3+, Yb3+ was carried 
out using a PHI 5600-ci spectrometer (Physical Electronics, Eden Prairie, MN, USA). A few 
drops of the aqueous suspension of nanoparticles were deposited on gold-coated silicon 
substrates which had been cleaned with a TL1 solution, which is a mixture of ultrapure water, 
30% H2O2 and 25% ammonia (Fisher, IL, USA; 5:1:1), at 80°C for 10 min). A monochromatic 
aluminum X-ray source (1486.6 eV, 300 W) was used to record the survey spectra (1400-0 eV) 
with charge neutralization. The detection angle was set at 45º with respect to the surface and the 
analyzed area was 0.005 cm2.  
 
3.6.7 Dialysis of PEG grafted NaGdF4: Tm3+, Yb3+ Nanoparticles 
Following the synthesis of PEG grafted NaGdF4: Tm
3+, Yb3+ nanoparticles, dialysis was 
performed in order to remove any unbound polymer. A membrane size 10 kD (Spectra/Por #6, 
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Spectrumlabs) was used and the nanoparticles were dialyzed for 24 h in ultrapure water. The 
water was changed three times during the 24 hours and the sample-to-volume ratio was kept to at 
1:1000.  
 
3.6.8 Dynamic Light Scattering (DLS)  
The hydrodynamic diameter and the zeta potentials of the nanoparticles were measured 
using dynamic light scattering (DLS, Malvern Zetasizer) The analyses were performed at 20°C 
in water. The analyses were performed at 25°C. The viscosity and refractive index of water were 
fixed at 0.8872 cP and 1.33, respectively. Three measurements were performed for each sample.  
 
 
3.6.9 Neutron Activation Analysis 
Neutron activation studies were carried out to determine the concentration of gadolinium 
in the samples. The concentration of gadolinium is necessary to determine the T1 and T2 
relaxivities. Samples to be analyzed consisted of the dialyzed nanoparticle dispersions in de-
ionized water. Samples prepared in plastic eppendorf tubes (100 μL) were introduced in the 
SLOWPOKE reactor for 100 seconds at a neutron flux of 1.0 x 1012 n.cm-2 s-1. The 153Gd (T1/2 = 
280 d) activities was measured. The monitors were counted 10 cm from a germanium detector. 
Activities were corrected for decay time and after a period of 21 days, the vials were counted 
with a Ge(Li) detector for 1000 seconds. 
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3.6.10 1H NMR Relaxivity Studies  
The proton relaxation rate was measurement using time domain NMR relaxometer 
(Bruker Minispec 60 MHz, 37 ℃). Dilution volumes of 400 μL (100, 75, 50, 25% v/v) of 
dialyzed suspensions were placed into 6.0 mm NMR tubes. Longitudinal and transversal 
relaxation times (T1 and T2) were performed in triplicate. The relaxation rates (1/T1 and 1/T2) 
were plotted against Gd3+ concentration values obtained from neutron activation studies, and the 
relaxivities (r1 and r2) were obtained from the slopes of the graphs.  
 
3.6.11 Magnetic Resonance Imaging and Contrast Agent Assessment  
In vitro assays of the contrast agent performance of ultra-small NaGdF4: Tm
3+, Yb3+ 
grafted with PEG and lysine were accomplished using a 1T ASPECT MR Scanner. The samples 
were placed in a bowl of nanopure water. The following T1 weighted parameters were used: echo 
time: 10.8 ms, repetition time 400 ms, a flip angle of 90°.  
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 Chapter Four- Results and Discussions 
4.1 Synthesis of Upconverting Nanoparticles (UCNPs) 
Upconverting nanoparticles may be synthesized by several different methods [7, 44, 45]. 
In this thesis, thermal decomposition and modified hydrothermal methods were used to produce 
UCNPs of size approximately 20 nm and 5 nm respectively. It is extremely important to obtain 
monodisperse nanoparticles such that the size dependent physiochemical properties may be 
investigated. Hence, an optimization of the thermal decomposition synthesis procedure was 
carried out.  
4.1.1 Controlled Size, Morphology and Particle Size Distribution of UCNPs NaYF4: Tm3+, 
Yb3+ via the Thermal Decomposition Method 
  The thermal decomposition synthesis method requires the optimization of several 
parameters such as the ratio of oleic acid/1-octadecene, precursor injection rate, reaction 
temperature and reaction time since they affect the size, morphology, crystal phase and particle 
size distribution of the UCNPs. Naccache [38] carried out a study that provides the optimal 
parameters for the thermal decomposition synthesis of NaGdF4 nanoparticles. In this thesis, the 
parameters obtained by Naccache [38] were used with the exception of the precursor injection 
rate. Thus, the precursor injection rate was investigated in order to ascertain its effect on the 
particle size distribution and morphology. This was carried out by varying the injection rate from 
0.3 mL/min. to 1.0 mL/min. and maintaining the temperature at 310℃ and the reaction time of 
60 min. The temperature and reaction time were selected based on the previous work carried out 
in the Capobianco research group.  
Transmission electron microscopy (TEM) analysis was carried out to investigate the 
effect of varying the injection rate on the particle size and morphology (Figures 4.1a and b).  






Figure 4.1: Transmission electrion microscopy images of NaYF4: Tm
3+, Yb3+ nanoparticles at (a) 
low magnification (30,500x) and (b) high magnification (179,000x) prepared as function of 
precursor injection rate. 
 
It is evident from the TEM images (low and high magnification) that the injection rate of 
0.75 mL/min produced the most uniform morphology and size of NaYF4 UCNPs. Particle size 
distribution analyses were carried out for the nanoparticles synthesized at different precursor 
injection rates and the narrowest distribution was observed at 0.75 mL/min (Figure 4.2) whereas 
a double distribution was observed for the 1.0 and 0.3 mL/min injection rates. The mean particle 
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size for the three precursor injection rates is reported in Table 4.1. The calculated standard 
deviation was the lowest for the 0.75 mL/min injection rate.  
Table 4.1: Mean particle size of NaYF4: Tm
3+, Yb3+ nanoparticles prepared as function of 
precursor injection rate. 
 
 
Figure 4.2: Particle size distribution of NaYF4: Tm
3+, Yb3+ nanoparticles prepared as function of 
precursor injection rate. 
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In the classical model of crystal growth in solution, the particles increase in size by the 
reaction with monomers (ions, atoms or molecules) present in solution. Therefore, different 
growth regimes may be distinguished that are dependent on the concentration of the monomers, 
which is related to the rate at which the monomers are added or removed from the particle 
surface. Ostward ripening [46, 47] is an observed phenomenon thermodynamically driven by 
concentration gradient. Oswald ripening is simply the process whereby small particles dissolve 
and release monomers while larger particles grow by the uptake of the monomers. That is 
because larger particles are energetically more stable than smaller particles. The other 
mechanism, which has been proposed is the La Mer mechanism [48, 49, 50], which described the 
separation of nucleation and growth in time. A high rate of nucleation leading to the burst of 
nuclei formation in a short period, consequently, the monomer concentration drops drastically 
below a point where no further nucleation is possible.  Eventually, a slow rate of growth leading 
to a long growth period compared to the nucleation period. There have also been reports that the 
growth could be the combination of the two mechanisms [51, 52].  The rate of addition of the 
precursors in the synthesis of UCNPs plays an important role in the process of crystal nucleation 
and growth. Crystal nucleation and growth are competitive processes. During the precursor 
injection period, as more precursors materials are being added into the reaction flask, new nuclei 
will be produced while previously formed nuclei continue to grow resulting in a polydisperse 
sample as observed for the rate of 0.3 mL/min (Figure 4.2c). At a faster addition rate of 1.0 
mL/min, the precursors are introduced at a much faster rate. This condition favors nucleation 
over growth since a higher concentration of decomposed precursor results in the formation of a 
large number of nuclei followed by growth over the length of the reaction time. Since a greater 
number of nuclei are formed at the higher addition rate, the particle size in expected to increase 
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as more decomposing precursor would be available to contribute to the growth. This is clearly 
shown in Figure 4.1a and b and Table 4.1. Particle size distribution analyses showed that an 
injection rate of 0.75 mL/min produced the narrowest distribution whereas the 1.0 mL/min and 
0.3 mL/min injection rate showed a double distribution indicating the polydispersity of the 
samples.  
The high resolution TEM images (Figure 4.3) of the synthesized nanoparticles (injection 
rate of 0.75 mL/min) showed that the particles are roughly spherical. In addition, from the high 
resolution TEM, the distance between the lattice fringes was measured to be 0.311 nm which 
corresponds to the d-spacing for the (111) lattice plane in the cubic structure of NaYF4. 
                                 
Figure 4.3: Lattice fringes observed in TEM image of NaYF4: Tm
3+, Yb3+ upconverting 
nanoparticles. The sample was prepared with 0.75 mL/min injection rate. 
 
The X-ray powder diffraction patterns for the samples synthesized using different 
injection rates are shown in Figure 4.4. Also shown in Figure 4.4 are the reference diffraction 
patterns for hexagonal (JCPDS 27-699) and the cubic (JCPDS 6-0342) phase of bulk NaYF4. In 
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addition, to the diffraction peaks of the cubic phase, the patterns also showed additional 
diffraction peaks (marked by *) that could not be attributed to neither phase. However, we were 
not yet able to identify the origin of these peaks and we simply attribute them to possible 
impurities [53].  
The XRD patterns were analyzed to ascertain the extent of formation of the cubic phase 
as a function of injection rate (Table 4.2). A maximum in the percentage of cubic phase was 
observed at an injection rate of 0.75 mL/min. The percent cubic phase was found to be the lowest 
at an injection of 0.3 mL/min suggesting that the conditions did not favor crystal growth.  
     
Figure 4.4: X-ray powder diffraction patterns of NaYF4: Tm
3+, Yb3+ nanoparticles prepared as 
function of precursor injection rate. 
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Table 4.2: Cubic phase composition in the samples of NaYF4: Tm
3+, Yb3+ prepared with 
different injection rate. 
 
The NaYF4: Tm
3+, Yb3+ upconverting nanoparticles showed emissions in the blue, red 
and NIR regions (Figure 4.5) following 980 nm excitation. The nanoparticles were prepared with 
different injection rate from 1.0 mL/min to 0.3 mL/min and were dispersed in toluene. All three 
samples showed the characteristic emissions of Tm3+ ions. The blue emissions located at 449 nm 
and 480 nm corresponded to 1D2 → 3F4 and 1G4 → 3H6 transitions respectively. The red emission 
located at 650 nm was assigned to the 1G4 → 3F4 transition. A strong intensity of NIR emission 
was centered at 800 nm, originated from the transition of 3H4 → 3H6. All three spectra were 
normalized to the NIR emission and the changes in the intensity of the blue emissions were 
observed and summarized in Table 4.3. Although we observed a slight change in the blue/NIR 
ratio for the UCNPs prepared at different injection rate, the changes in the blue/NIR ratio is 
within 10% (within experimental errors). Since the three different injection rate resulted UCNPS 
of different particle size distribution, for example, the injection rate of 0.75 mL/min has resulted 
in UCNPs of 19.4 ± 2.0 nm. The injection rate of 0.30 mL/min has resulted the smallest particle 
size 11.4 ± 2.0 nm. Theoretically, smaller nanoparticles with more surface defects are expected 
to have smaller blue/NIR ratio since upconversion is a multiphoton process, the generation of 
blue emissions requires absorption of three photons, whereas the NIR emission requires only two 
photons (Figure 2.3). Therefore, small nanoparticles with more surface defects will be less 
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efficient than the large nanoparticles in the upconversion processes. The results obtained were 
consistent with the theory. The injection rate of 0.75 mL/min which resulted in the largest 
particle size with the narrowest particle size distribution among the three showed the highest 
blue/NIR ratio.  And the injection rate of 0.3 mL/min resulted in smallest particle sizes showed 
smallest blue/NIR ratio.  
 
 
Figure 4.5: Upconversion emission spectra of NaYF4: Tm
3+, Yb3+ nanoparticles (1 w% 
dispersion in toluene) prepared as function of precursor injection rate, following 980 nm 
excitation. Upconversion emission was ascribed to the transitions of (I) 1D2  3F4, (II) 1G4  
3H6, (III) 
1G4  3F4, (IV) 3H4  3H6 
.  
 
   44 
Table 4.3: Blue/NIR luminescence ratio for of NaYF4: Tm
3+, Yb3+ nanoparticles as function of 
injection rate. 






4.1.2 Synthesis of Ultra-small NaGdF4: Tm3+, Yb3+  
For applications in nanomedicine, there are rigorous requirements. Particularly for 
multimodal bioimaging, a small particle diameter (<5 nm), bright luminescence, and non-toxicity 
are required. Despite the recent progress in the synthesis of ultra-small lanthanide-doped 
nanocrystals, the development of reproducible facile synthetic routes that yield reliably 
ultrasmall fluoride inorganic nanocrystals is still a tremendous challenge. In this section, we 
report the synthesis of ultra-small NaGdF4: Tm
3+, Yb3+ nanoparticles and their potential 
application as bimodal probes (optical and magnetic resonance). The requirement for ultra-small 
NaGdF4 nanoparticles stems from the fact that the concentration of Gd
3+ ions will increase at the 
surface since the surface to volume ratio increases as the size of the nanoparticle decreases thus 
providing a greater water Gd3+ interaction, which is a primordial requirement for MRI.  
The thermal decomposition synthesis of UCNPs requires high temperature to decompose 
the trifluoroacetates. Thus, the reaction favors the growth stage of nanocrystals, resulting in 
nanoparticles which are larger than 10 nm. The synthesis of UCNPs as small as 3 – 5 nm while 
maintaining a narrow size distribution requires a synthetic route that yields reliably ultra-small 
UCNPs.  
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The parameters which may be controlled in the thermal decomposition synthesis and 
which may impact the formation of the nanoparticles are: reaction time, reaction temperature, 
precursor addition rate and the oleic acid capping ligand to 1-octadecene non co-ordinating 
ligand solvent ratio. All of these parameters have been studied previously by Naccache [38] and 
the author demonstrated the difficulties in controlling these parameters to obtain ultra-small 
nanoparticles. Thus, we employed the synthetic route described in Section 3.3 of this thesis, 
which has been shown to produce high quality ultra-small UCNPs.  
The TEM and particle size distribution revealed the synthesized NaGdF4: Tm
3+, Yb3+ 
nanoparticles have a high degree of uniformity in size (Figure 4.6a) and shape (Figure 4.6b). The 
mean particle size was determined to be 5.1 ± 0.5 nm in a size range of 4 – 6 nm. Therefore, the 
synthesis procedure yields nanoparticles, which are ultra-small and highly monodisperse.  
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Figure 4.6: Transmission electron microscopy images of ultra-small NaGdF4: Tm
3+, Yb3+ 
nanoparticles at a) low magnification (65,000X), b) high magnification (140,000X). Panel c) 
shows particle size distribution of ultra-small NaGdF4: Tm
3+, Yb3+. 
The selected area electron diffraction (SAED) pattern of the particles (Figure 4.7) can be 
indexed to the (111), (200), (220) and (311) planes of the standard cubic structure. The emission 
spectrum obtained upon 980 nm excitation of the ultra-small NaGdF4: Tm
3+, Yb3+ is shown in 
Figure 4.8. Four Tm3+ emission bands were observed. The two bands observed in the blue 
c) 
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regions of the spectrum 450-480 nm were assigned to the 1D2  3F4, and 1G4  3H6 transitions 
respectively. A weak red emission at 640-670 nm and an intense NIR emission at 750-850 nm 
were assigned to the 1G4  3F4 and 3H4  3H6  transitions respectively. It should be noted that 
the transitions are a result of the upconversion process which has been discussed extensively 
over the past years.  
 
 
Figure 4.7: The selected area electron diffraction (SAED) pattern of ultra-small NaGdF4: Tm
3+, 
Yb3+. 
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Figure 4.8: Upconversion emission spectra of ultra-small NaYF4: Tm
3+, Yb3+ nanoparticles 
following 980 nm excitation. Upconversion emission was ascribed to the (I) 1D2  3F4, (II) 1G4 
 3H6, (III) 1G4  3F4, (IV) 3H4  3H6. 
4.2 Surface Modifications of the Nanoparticles towards Water Dispersibility and 
Multimodalities 
 
We have used two different synthetic routes to produce UCNPs that show a narrow 
particle size distribution as well as uniformity in their morphology. However, both synthetic 
routes resulted in the formation of hydrophobic nanoparticles. They have no intrinsic aqueous 
dispersibility and lack functional moieties for subsequent biological functionalization due to the 
hydrophobic oleate capping ligand. This is a major drawback in biomedical research. Post 
synthesis surface modifications have been employed to render these nanoparticles dispersible in 
aqueous media such as ligand exchange with citrate [54], silica coating [55, 56], oxidation of the 
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oleate capping ligand to azelaic acid and the removal of the oleate ligand by a simple acid 
treatment [57] that produces ligand free water dispersible nanoparticles.   
Two approaches could be used for the design of a bimodal contrast agent. The optical 
properties could be strictly from the core of the upconverting nanoparticles. The Gd3+ ions, 
which provide T1 contrast enhancement in MRI, could be functionalized onto the surface of 
UCNPs as Gd3+ complex or Gd3+ ions may be incorporated directly in the UCNPs.  
In order to functionalize Gd3+ chelates onto the crystalline surface of the UCNPs, silica 
coating is a suitable approach since it would provide water dispersibility and covalent bonding of 
the Gd3+ chelates to the surface of UCNPs. NaYF4: Tm
3+, Yb3+ was chosen as the core of the 
nanoconstruct to provide the optical properties required and the MRI signals will arise strictly 
from the Gd3+ chelates anchored to the surfaces of the UCNPs.   
The second approach of incorporating of Gd3+ ions in the nanocrystal required 
maintaining a high concentration of Gd3+ ions per nanoparticle without having any adverse effect 
on the upconverting property. Ultra small nanoparticles provide high surface area to volume ratio, 
therefore, ultra-small NaGdF4: Tm
3+, Yb3+ may be used as the base material for the design of the 
bimodal contrast agent. Moreover, considering water molecules must have direct contact with 
Gd3+ ions on the surface of the nanocrystals, polymer coating is the preferred approach compared 
to silica coating.  
 
4.2.1 Silica Coating  
The technique used to perform silica coating experiment was the reverse micro-emulsion. 
The hydrophobic UCNPs were dispersed in non-polar solvent such as cyclohexane. Koole et al. 
discussed the role of the surfactant Igepal CO-520, which functioned not only to ligand exchange 
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with the capping ligand oleate, but also formed a micelle around individual nanoparticles. The 
formation of micelles allows water, ammonium hydroxide and TEOS (tetraethyl orthosilicate) to 
migrate into the core of micelles [58] (Figure 4.9). The hydrolysis of TEOS was catalyzed in 
basic conditions, resulting in the formation of a silica shell around the nanoparticles. The ratio of 
concentration of UCNPs/TEOS was optimized in order obtain individually coated UCNPs. 
 
Figure 4.9: Proposed mechanisms for silica coating of nanoparticles [58]. 
The starting materials, UCNPs NaYF4: Tm
3+, Yb3+ were prepared using the following 
conditions: 310 ℃, 0.75 mL/min of injection rate, one hour of reaction time. The as-synthesized 
UCNPs with a mean particle size of 19.4 ± 2.0 nm were dispersible only in non polar solvents. 
Following silica coating, we observed a thin layer of silica shell of approximately 4-5 nm grown 
on each nanoparticle based on the TEM images in Figure 4.10c. Hence, the mean particle size of 
the silica coated UCNPs increased to 27.6 ±  3.0 nm (Figure 4.10d). One problem often 
encountered in silica coating of nanoparticles is agglomeration. Due to optimal reaction 
conditions, both TEM images and particle size distributions (Figure 4.10) showed the success of 
silica coating of UCNPs. Therefore, not only was the narrow size distribution maintained, more 
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importantly silica coated UCNPs are hydrophilic. The formation of the silica shell on the UCNPs 
was verified to be silica by Fournier transform infrared (FTIR) spectroscopy.  The FTIR 
spectrum shown in figure 4.11a shows  the characteristic peak of the oleate capping ligand before 
surface modification: the peaks observed at 2925, 2852 cm -1 corresponded to the C-H stretching 
from the carbon chains and the partial C=O bond stretching of carboxylate groups at 1562, 1467 
cm -1. These characteristic peaks of the oleate capping ligand are not observed in the FTIR 
spectrum (Figure 4.11b) of the silica coated UCNPs. The spectrum (Figure 4.11b) showed the 
following peaks, which were attributed to the asymmetrical and symmetrical O-Si-O stretching 
at 1090 and 953 cm -1 respectively; Si-C stretching at 800 cm -1 and O-H bending at 1637 cm -1. 
Therefore, the silica shell on the UCNPs was confirmed by FTIR 
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Figure 4.10: Transmission electron microscopy of silica coated NaYF4: Tm
3+, Yb3+ nanoparticles 
at magnifications a) 22,000X; b) 57,000X and c) 135,000X; d) particle size distribution of silica 
coated NaYF4: Tm
3+, Yb3+ nanoparticles. 
d) 
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Figure 4.11: FT-IR spectra of (a) oleate capped and (b) silica coated UCNPs NaYF4: Tm
3+, Yb3+ 
nanoparticles. 
4.2.1.1 Introducing Azide Functional Groups on the Surface of Silica Coated UCNPs 
The FTIR results of the silica coated UCNPs showed the presence of hydroxyl groups on 
the surface. In order to covalently conjugate the Gd3+ chelates, for example, Gd-DOTA to silica 
coated UCNPs, it is necessary to modify the silica surface to provide functional groups, which 
will allow covalent bonding to Gd-DOTA. Among all conjugations techniques, the click reaction 
introduced by Sharpless et al. has been shown to be the most convenient route since it is easy to 
perform and provides high yield. It involves a 1,3-dipolar cycloaddition between an azide and an 
alkyne functional group, which results in a 1,2,3-triazole [59]. The first step involves the surface 
modifications of silica coated UCNPs to bear the N3 terminal group, which was confirmed by 
comparing FTIR spectra. Before the modification with azide silane, Figure 4.12a showed the 
(a) 
(b) 
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characteristics peaks of silica at 3419, 1087, 958 and 800 cm -1 (the assignments were discussed 
in the previous section). The appearance of the peaks at 2937 cm -1 (alkyl C-H stretching) and at 
2107 cm -1 (N≡N asymmetric stretching) in the FTIR spectrum (Figure 4.12b) suggested the 
presence of azide groups on the surfaces of silica coated UCNPs following the surface 
modification.  
 
         
Figure 4.12: FT-IR of (a) silica coated UCNPs and (b) azide modified UCNPs 
 
4.2.1.2 Functionalization of Silica Coated UCNPs with Alkyne Gd-DOTA via the Click 
Reaction 
Silica coating has rendered the UCNPs water dispersible and the addition of the azide 
group allowed for the functionalization of the UCNPs with the alkyne Gd-DOTA for the design 
of a bimodal (optical, MRI) nanoconstruct for bioimaging using the click reaction. The reaction 
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to produce the alkyne terminated Gd-DOTA is shown in Appendix A. Figure 4.13 shows the 
reaction scheme for the conjugation of the alkyne Gd-DOTA to the surface of the UCNPs.  
 
 
Figure 4.13: The reaction scheme of the conjugation of a MRI contrast agent Gd-DOTA to an 
azide modified silica coated NaYF4: Tm
3+, Yb3+  nanoparticles. 
 
Briefly, the reaction of the alkyne and azide moieties was catalyzed by Cu(I) at room 
temperature. Sodium ascorbate was used to reduce Cu(II) to Cu(I). During the reaction, the color 
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of the solution was observed to change from light blue to light yellow, which was an indication 
of the presence of the catalyst Cu(I) (Figure 4.14). 
                         
Figure 4.14: Sodium ascorbate reduced Cu(II) to Cu(I) during the click reaction. The color of the 
solution changed from light blue to light yellow. 
 
To ascertain the presence of the Gd-DOTA complex on the surface of the silica coated 
UCNPs, FTIR spectroscopy was employed. Figure 4.15a, b, c shows the FTIR spectra of the 
alkyne terminated Gd-DOTA, of the azide modified silica coated UCNPs and the final product 
which is UCNPs functionalized with the Gd-DOTA complex respectively. In Figure 4.15a, the 
following peaks in the FTIR spectrum were observed and the compound was confirmed to be 
alkyne terminated Gd-DOTA: peak at 3307 cm-1 was attributed to N-H stretching of amide; 2993 
cm-1 (C-H stretching); 2128 cm-1 (C≡C stretching); a pair of peaks at 1697 and 1404 cm-1 
(asymmetric and symmetric stretching of  partial C=O of carboxylate); 1625 cm-1 (C=O 
stretching of amide); 1209 cm-1 (C-O stretching) and 1132 cm-1 (C-N stretching). Figure 4.15b 
showed the characteristics peaks of the azide modified silica coated UCNPs at 2933, 2108 and 
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1099 cm -1 (the assignments were discussed in the previous section). The FTIR spectrum in 
Figure 4.15c represents the final product following the click reaction. The characteristics peaks 
of silica were observed in the spectrum, which were expected: 1091, 957, 805 cm -1 (the 
assignments were discussed in section 4.2.1). Comparing the spectrum (b) the azide modified 
silica coated UCNPs to the spectrum (c) the product formed following the click reaction in 
Figure 4.15, the first important difference was the disappearance of the peak at 2108 cm-1 (N≡N 
asymmetric stretching) in Figure 4.15c, indicating the completion of the click reaction. The 
second important difference was the appearance of the peak at 1648 cm-1, which corresponded to 
the peak of the highest intensity from Figure 4.15a, which was identified to be the asymmetrical 
C=O stretching of the carboxylate group for alkyne terminated Gd-DOTA. 
 
Figure 4.15: FT-IR spectra of (a) alkyne Gd-DOTA; (b) azide modified silica coated 
upconverting nanoparticles NaYF4: Tm
3+, Yb3+; (c) nanoconstruct following the click reaction. 
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The FTIR results provide evidence for the conjugation of Gd-DOTA onto the surface of 
the UCNPs using the click reaction. Further evidence for the formation of (Gd-DOTA)-UCNP 
nanoconstruct may be obtained by comparing the T1 and T2 relaxivities of the alkyne Gd-DOTA 
complex to those obtained for the nanoconstruct since the tumbling rates for the two systems 
should be different. As a MRI contrast agent, the tumbling rate plays an important role in the 
enhancement the relaxation rate of water molecules, which is defined by the relaxivity. In order 
to evaluate the enhancement effect of the two contrast agents, the alkyne Gd-DOTA complex 
and the (Gd-DOTA)-UCNP, a relaxometry experiment was carried out.  
Since the paramagnetic contribution on the relaxation rate is directly proportional to the 
concentration of the contrast agent, an accurate determination of the Gd3+ ion concentration in 
the two samples was required, which was performed using ICP-MS. The calibration curve for 
gadolinium in ICP-MS analysis was first established (Figure 4.16) using Gd3+ ions as the 
standard reagents from 0.1 to 1.0 ppm. This method required digestion of the samples in 
concentrated nitric acid prior ICP-MS analysis. The calibration curve was used to determine the 
Gd concentration of the alkyne Gd-DOTA complex and the nanoconstruct (Gd-DOTA)-UCNP. 
The analysis results were obtained in ppm, which were converted to mM since the unit of 
relaxivity is normally expressed in mM-1 s-1.   
Time domain NMR was employed to measure the proton relaxation rate of the two 
samples. The samples were prepared as 100% (stock solution) along with dilutions at 75, 50, and 
25 % v/v. The corresponding T1 and T2 relaxation rates of the samples were plotted against Gd 
concentration (Figure 4.17 a, b).  The slopes of the linear plots represent the T1 and T2 
relaxivities, denoted using parameters r1 and r2. The results were summarized in Table 4.4. The 
T1 and T2 relaxivities of alkyne Gd-DOTA were found to be 3.4 and 3.9 mM
-1 s-1 respectively. 
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These values were in accordance to the literature data [36]. However, the T1 and T2 relaxivities 
of the nanoconstruct were found to be 16.9 and 28.2 mM-1 s-1 respectively, which were 
significantly higher than the Gd3+ chelates (Table 4.4).  These results were expected since 
immobilizing gadolinium complex to nanoparticles of size 27 nm, had effect of significantly 
reducing the tumbling rate of the system, allowing for more water molecules to be interacted 
with Gd3+ per second [60, 61]. The T1 relaxivity or longitudinal relaxivity directly refers to the 
efficiency of a contrast agent in the enhancement of water relaxation rate. The higher the 
relaxivity suggests the better enhancement effect. These results not only indicated the success of 
the click reaction, the covalent conjugation of Gd-DOTA to the upconverting nanoparticles, but 
it also showed the potential benefits of the nanoconstruct for MR imaging.  
 
 
Figure 4.16: Calibration curve for gadolinium in ICP-MS analysis. 
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                                                                           (a) 
                    
                                                                              (b) 
Figure 4.17: T1 and T2 relaxivities plots for (a) nanoconstruct Gd-DOTA-(UCNPs)  and (b) 
alkyne Gd-DOTA. 
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Table 4.4: T1 and T2 relaxivities of alkyne Gd-DOTA and the nanoconstruct in water under 
physiological conditions (37 ℃ and pH = 7) at 60 MHz 
 Alkyne_Gd-DOTA Nanoconstruct 
T1 relaxivities 3.38 16.90 
T2 relaxivities 3.94 28.25 
 
The optical properties of the nanoconstruct were characterized using luminescence 
spectroscopy. The nanoconstruct is composed of the core NaYF4: Tm
3+, Yb3+, of silica shell and 
the MRI contrast agents Gd-DOTA conjugated onto the surface. Figure 4.18 shows the 
upconversion emission spectra of the nanocontruct (Gd-DOTA)-UCNPs, following 980nm 
excitation. The nanoconstruct clearly showed the characteristic transitions of Tm3+.  The blue 
emission peaks observed at 450 nm and 480 nm were attributed to the 1D2  3F4 and 1G4  3H6 
transitions respectively.  The red emission peak at 650 nm was assigned to the 
1G4  3F4 
transition and finally the most intense emission peak at 800 nm was assigned to the 3H4  3H6 
transition.   
The upconversion spectrum of the nanoconstruct in Figure 4.18 was normalized to the 
NIR emission peak at 800 nm from the spectrum of the starting material, oleate capped NaYF4: 
Tm3+, Yb3+ dispersed in toluene, which gave higher upconversion efficiency in nonpolar solvent.  
The overall luminescence intensity of the nanoconstruct was observed to be weaker compared to 
the oleate capped UCNPs dispersed in toluene. This is likely due to the high efficiency of the 
vibrations of water molecules in bridging the energy gaps separating the emitting levels of the 
thulium(III) ions. The NIR: Blue ratio for the nanoconstruct was calculated to be 6.68 whereas 
the oleate capped UCNPs has a NIR: Blue ratio of 8.34 (the area of the peak at 800 nm versus 
the area of the peak at 480 nm.) The lower NIR: Blue ratio for the nanoconstruct showed 
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quenching in the intensity of the NIR at 800 nm, which is likely due to silica phonons in bridging 
the energy gap of 3H4  3H6 transition.  However, the decrease in intensity of the NIR emission 
peak is not as significant as expected, which shows the efficiency of NIR-NIR excitation-
emission process of the silica coated nanoconstruct in water, and it shows that the nanoconstruct 
has potential to be used as in vivo optical probe.  
 
Figure 4.18: Luminescence spectrum of 1 wt% nanoconstruct (Gd-DOTA)-UCNPs dispersed in 
water, following excitation of 980 nm. The emission spectrum was normalized to the NIR at 800 
nm of 1 wt% oleate capped UCNPs NaYF4: Tm
3+, Yb3+ dispersed in toluene. Upconversion 
emission was ascribed to the transitions of (I) 1D2  3F4, (II) 1G4  3H6, (III) 1G4  3F4, (IV) 3H4 
 3H6. 
 
Finally, we have demonstrated the synthesis of bimodal nanoconstruct, which is the  
functionalization of Gd chelates onto the UCNPs NaYF4: Tm
3+, Yb3+ , resulting in higher  
relaxivities than commercial MRI contrast agents. The nanoconstruct possesses unique optical 
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property. Its NIR-to-NIR excitation-emission was shown to be effective in water, which renders 
this system suitable for bioimaging since both excitation and emission fall within the biological 
window. Meanwhile, we are exploring alternative ways for designing a contrast agent which 
would offer optical and paramagnetic properties.  
 
4.2.2 Design of a Blood Pool Contrast Agent (Polymer Coating of Ultra-small UCNPs) 
Low molecular weight of Gd3+ chelates are rather inefficient for imaging of arteries or 
veins due to rapid diffusion rate and short circulation time in the blood vessels (early distribution 
phase t1/2 ≈ 10 min; elimination t1/2 ≈ 1.5 hours). Morever, the major problem associated with 
the low molecular weight contrast agents (CAs) is the rapid tumbling motion resulting in low 
relaxivity. Therefore, another class of contrast agents, known as blood pool CAs, have been 
designed to address both the need for longer vascular retention times and the higher relaxivity 
[62].  
Due to their higher molecular weight, blood pool CAs provide longer circulation times 
resulting in longer image acquisition window, which may be used to increase both the signal-to-
noise ratio and to improve image resolution [63]. The previous sections presented the 
functionalization of Gd3+ chelates onto upconverting nanoparticles leading to higher relaxivities. 
Another approach for designing T1 CAs would be the incorporation of Gd
3+ into the 
nanocrystalline system. The advantages of this approach include simple synthetic procedure 
which would not involve the tedious functionalization of Gd3+ chelates; a higher concentration of 
Gd3+ ions per nanoparticle; control of targeting and clearance making use of the surface 
chemistry. Capobianco’s group reported the relaxivities values and the r1/r2 ratio of citrate 
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capped ultra-small NaGdF4: Tm
3+, Yb3+ (<5 nm diam.,) which was found to be very similar to 
commercial Gd3+ chelates and provided efficient positive contrast for MRI. However, the results 
of biodistribution of citrate capped US-UCNPs showed a strong uptake of nanoparticles by the 
liver after 48h and after 8 days [9].  In general, when nanoparticles are administered into the 
blood, they are taken up by the phagocytic cells of the mononuclear phagocyte system (MPS) 
[64].  The retention time and the clearance rate of nanoparticles depend on many factors; 
however, size and surface chemistry play a predominant role. For example, positively charged 
nanoparticles are taken up at a faster rate in comparison to neutral or negatively charged 
nanoparticles [65]. It has been suggested that the rate of clearance rate can be reduced by adding 
poly(ethylene) glycol (PEG) to the surface of nanoparticles. In addition, PEG prevents antibody 
opsonisation, and drastically increases the blood half-life of nanoparticles [66]. It has also been 
shown that nanoparticles with diameters smaller than 6 nm may be eliminated by the kidneys 
[67].   Without such clearance route, the biodegradation of nanoparticles could potentially lead to 
toxic components. Therefore, a new class of blood pool CAs was designed using ultra-small 
NaGdF4: Tm
3+, Yb3+ as base material, which are to be functionalized with PEG polymer. The 
aim was to prolong the circulation time in the blood vessels and to control clearance via renal 
route.  
The design of a blood pool CAs for MRI involved first the synthesis of ultra-small 
NaGdF4: Tm
3+, Yb3+ (US-UCNPs) (section 4.1.2) followed by coating the surface of the 
nanoparticles using PEG diacid. We selected PEG of relatively low molecular weight (Mn = 600) 
and with two carboxylate groups, which functioned as anchor groups to bind the positively 
charged surface of the US-UCNPs. Oleate was the capping ligand of the starting material, which 
also has one carboxylate group that binds to the positively charged surface of US-UCNPs. 
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Therefore, the two ligands compete to bind to the surface of UCNPs. In order to displace all 
oleates, theoretically, PEG polymer has to be provided in higher concentration compared to the 
oleates. Then, the high PEG concentration pushes the position of the equilibrium to the right 
according to Le Chatelier’s Principle. It was observed that the ligand exchange process was 
efficient at pH 3-4, at 40 ℃. The DLS results shown in Figure 4.19a,b were the nanoparticles 
obtained after ligand exchange reaction, dispersed in aqueous solution. The concentration of 
PEG diacid at 0.02 M resulted in US-UCNPs of hydrodynamic diameter of 436 nm whereas a 
relatively higher PEG diacid concentration of 0.2 M gave nanoparticles in smaller hydrodynamic 
diameter of 55 nm. It is evident that 0.02 M of PEG diacid was not sufficient to displace all 
oleate on the surface of US-UCNPs, which caused the nanoparticles to agglomerate in aqueous 
solution. When PEG diacid was present at higher concentration, 0.2 M during the ligand 
exchange process, more oleate on the surface of US-UCNPs were being replaced, this has 
resulted in colloidally more stable nanoparticles, indicated by smaller hydrodynamic diameter. 
 
Figure 4.19: Hydrodynamic diameter of PEG grafted US-UCNPs using (a) 0.2 M of PEG diacid; 
(b) 0.02 M of  PEG diacid determined by DLS. Both sets of nanoparticles were dispersed in 154 
mM NaCl solution, pH 5. 
(a) (b) 
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Polymer coating of US-UCNPs rendered the nanoparticles water dispersible. To be used 
as a blood pool agent, the PEG coated-UCNPs must be stable in the commonly used saline 
solution (154 mM NaCl). Dynamic light scattering (DLS) was used to evaluate the colloidal 
stability of the PEG coated US-UCNPs over a period of one month. The hydrodynamic 
diameters of the PEG coated US-UCNPs dispersed in the saline solution after the dialysis (day 1), 
day 7, and day 30 was observed to be 51 nm, 51 nm and 59 nm. Therefore, it is concluded that 
the hydrodynamic diameters of the PEG coated US-UCNPs dispersed in the saline solution did 
not change after 7 days demonstrating that the nanoparticles are stable and that no agglomeration 
occurred (Figure 4.20).   
 
 
Figure 4.20: Colloidal stability evaluation of PEG coated US-UCNPs dispersed in 154 mM 
saline solution as function of time (pH 5), by DLS. 
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Figure 4.21a,b show the TEM images of oleate capped US-UCNPs and PEG coated US-
UCNPs respectively. It is evident from the TEM images (Figure 4.21a) that the oleate capped 
US-UCNPs show no agglomeration. The oleate capped US-UCNPs appeared to be distant from 
each other in a homogeneous fashion, which is due to interdigitation of the hydrocarbon chains 
from the oleate. In Figure 4.21b, the PEG coated US-UCNPs formed small clusters, and the 
nanoparticles self-assembled via an attractive interaction. Since PEG diacid has a carboxylic acid 
group at each end of the polymer chain, it is speculated that certain carboxylic acid groups were 
not chelated by the lanthanides ions of the US-UCNPs and were exposed on the outer surface of 
the nanoparticles leading to hydrogen bonding with other PEG coated nanoparticle. This could 
possibly explain why the US-UCNPs were closely bound to each other as shown in Figure 4.21b.  
 
 
Figure 4.21: TEM images of (a) Oleate capped US-NaGdF4: Tm
3+, Yb3+ ; (b) PEG coated US-
NaGdF4: Tm
3+, Yb3+ (The nanoparticles were dispersed in aqueous solution of  pH 5, 154 mM of 
saline). 
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Following the ligand exchange reaction and dialysis, the solution where the PEG coated 
US-UCNPs were dispersed was found to be at pH 5. The pH was adjusted for the zeta potential 
measurement. Table 4.5 showed the zeta potential of PEG coating of US-UCNPs in solutions at 
different pH. Zeta potential is usually employed as indication of the degree of stabilization of a 
colloidal system. Large zeta potential of ± 25 mV usually indicates a stable colloidal system that 
nanoparticles resist aggregation [68]. PEG coated US-UCNPs gave a relatively low zeta potential 
value of – 4.95 mV at pH 5 in 154 mM of saline solution.  However, both DLS and TEM results 
which were measured at the same conditions suggested that these nanoparticles were stable since 
no severe aggregation was observed (Figure 4.19a and 4.21b). In fact, colloidal stability is 
imparted by the combination of electrostatic and steric effects. Generally, polymers provide 
stability to colloids through steric stabilization [69, 70]. Therefore, the colloidal stability of PEG 
coated US-UCNPs was due to steric repulsion of the polymers on the surface of the nanoparticles. 
This explains why PEG coated US-UCNPs did not aggregate despite the low zeta potential. PEG 
coating of nanoparticles provided good colloidal stability and low surface charge, which could 
result in interesting biological effects. It was discussed that surface charge played an important 
role in the rate of nanoparticles uptake by the phagocytic cells of the mononuclear phagocyte 
system (MPS). Nanoparticles with close to zero surface charge are expected to give longer 
retention time in blood circulation which could be advantageous in bioimaging. 
 
Table 4.5: Zeta potential of PEG coated US- NaGdF4: Tm
3+, Yb3+ in deionized water. 
pH of the solution Zeta Potential (mV) 
3 - 0.52 
5 - 4.95 
7 - 8.89 
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US-UCNPs and the PEG diacid respectively. The oleate capping ligand was characterized 
in spectrum (b): the peak at 3010 cm -1 corresponded to the sp2 C-H stretch; the peaks observed 
at 2923, 2856 cm -1 corresponded to the sp3 C-H stretch; the asymmetrical and symmetrical 
partial C=O bond stretch of carboxylate groups were found at 1562, 1467 cm -1. The PEG diacid 
solution (pH = 3) which was to be used for the ligand exchange reaction was characterized in 
spectrum (c): the peak at 2870   cm -1 corresponded to the sp3 C-H stretch, the peak at 1756 cm -1 
corresponded to the C=O stretch of the carboxylic acid and the peak at 1115 cm -1 corresponded 
to the C-O stretch. Following the ligand exchange reaction, the products showed the 
characteristics peaks of PEG diacid on spectrum (a): 2866 cm -1 which corresponded to the sp3 C-
H stretch, 1751 cm -1  corresponded to the C=O stretch. The peak at 1097 cm -1  which 
corresponded to the C-O stretch. The pair of peaks found at 1616 and 1469 cm -1 which was 
present in the spectrum of PEG diacid, corresponded to the asymmetrical and symmetrical 
stretches of the carboxylate. Therefore, we confirmed the success of the ligand exchange reaction 
and that the US-UCNPs were coated by PEG diacid.  
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Figure 4.22: FTIR spectra (a) PEG capped US- NaGdF4: Tm
3+, Yb3+ ; (b) oleate capped US- 
NaGdF4: Tm
3+, Yb3+ ; (c) PEG diacid pH = 3. 
 
X-ray photoelectron spectroscopy (XPS) was employed to confirm the presence of PEG 
on the surface of US-UCNPs.  Figure 4.23 shows magnified regions of the XPS spectrum for 
PEG coated US- NaGdF4: Tm
3+, Yb3+. From the XPS data, the ratio of carbon / oxygen was 
calculated to be 2:1 which is consistent to stoichiometric ratio of carbon / oxygen of the PEG 
diacid showing below.  
 
 





Figure 4.23: XPS spectrum for PEG coated US- NaGdF4: Tm
3+, Yb3+ magnified region (a) 538 – 
526 eV for oxygen (1S); (b) 294 –280 eV for carbon (1S); (c) 155 – 140 eV for gadolinium (4d). 
 
 Both FTIR and XPS results confirmed the capping ligand on the US-UCNPs to be PEG 
acid. It is important to study the effect of the capping ligand on the relaxivity of US-UCNPs. 
Therefore, a relaxometric experiment was performed by comparing lysine coated US-UCNPs 
and PEG coated US-UCNPs. The structures of both ligands are shown below. Lysine, an amino 
(b) C 1s 
(c) Gd 4d 
 
- 531.0 eV : Gd – O 






- 284.6 eV: C-C/C-H 
- 285.5 eV : C-O  
- 287.2eV : C=O 
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acid with molecular weight of 146 g/mol, has one carboxylic acid and two amine groups. PEG 
diacid, a polymer has average molecular weight of 600 g/mol. The characterization on lysine 
coated nanoparticles is shown in Appendix B.  
 
Both lysine and PEG coated US-UCNPs dispersed in water were prepared in a diluted 
series of 100 % (the dialyzed dispersion), 75%, 50 % and 25% v/v prior relaxometric 
measurement. The Gd concentration of each set of the samples was determined using neutron 
activations since it has been shown that the ICP-MS/ICP-AES techniques which involve the 
digestion procedures of the sample using concentrated nitric acid caused an underestimate the 
concentration of lanthanide ions in the sample [71].  The proton relaxation rate of each set of the 
samples was measured using time domain NMR. Figure 4.24a,b shows the plots of proton 
relaxation rate vs. Gd concentration for PEG coated and lysine coated US-UCNPs respectively. 
The T1 and T2 relaxivities were determined as the value of the slopes from the linear plots, 
denoted r1 and r2 respectively. The relaxometric results were summarized in table 4.6.  
The T1 and T2 relaxivities of lysine grafted US-UCNPs were found to be 3.61 and 5.24 
respectively. These values were very close to the citrated capped US- NaGdF4: Tm
3+, Yb3 
reported by Naccache R. et al. (r1=3.37, r2=3.96, r2 / r1 =1.18)
 [9].  In contrast, PEG coated US-
UCNPs gave slightly higher T1 and T2 relaxivities, 5.79 and 7.41 respectively. These results were 
expected since both lysine and citrate have lower molecular weight compared to PEG. Coating 
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PEG polymer on the surface of US-UCNPs has the effect of slowing down the tumbling rate, 
thus resulting in higher relaxivities. Moreover, since a MR contrast agents affect both T1 and T2 
relaxation rate simultaneously, the ratio between the T2  and T1 relaxivities (expressed as r2/r1), is 
commonly used to assess the efficiency of a MR contrast agent. The ratio r2/r1 provides an 
indication as to whether the contrast agent can be employed as a positive or negative CA. An 
efficient T1 contrast agent must have a large paramagnetic property with negligible magnetic 
anisotropy. Typically, T1 contrast agents have r2/r1 ratio approaching 1 whereas commercial iron 
oxide nanoparticles used in T2-weighted MRI imaging has a r2/r1 ratio between 6-15 [72].
 The 
ratio r2/r1 of PEG and lysine grafted US- NaGdF4: Tm
3+, Yb3+ were calculated to be 1.28 and 









Figure 4.24: T1 and T2 relaxivities plots for (a) PEG coated US- NaGdF4: Tm
3+, Yb3+; (b) lysine 
coated US- NaGdF4: Tm
3+, Yb3+. 
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Table 4.6: Relaxometric results of US- NaGdF4: Tm
3+, Yb3+ coated by different ligands. 
 
The T1 and T2 contrast enhancement abilities were evaluated with in vitro MRI. The 
lysine and PEG coated US-UCNPs were prepared in a set a diluted samples 100% (dialyzed 
dispersion), 75%, 50% and 25% v/v, which had been previously  measured by time domain 
NMR, were to be analyzed in a MR Scanner of 1 Tesla. Figure 4.25a,b shows the T1 and T2 
weighted images of the lysine coated US-UCNPs, the PEG coated US-UCNPs and a water 
sample (a negative control).  In the T1 weighted image (Figure 4.25a), all the spots containing 
lysine and PEG coated US-UCNPs appeared to be brighter than the control, indicating the 
positive contrast enhancement by the US-NaGdF4: Tm
3+, Yb3+. The contrast decreased with 
decreasing concentration of Gd. On the other hand, in the T2- weighted image (Figure 4.25b), all 
the spots containing lysine and PEG coated US-UCNPs were not showing darker compared to 
the control, indicating there was not significant T2 effect contributed by the ultra-small sized 
UCNPs. Therefore, the low r2/r1 ratio and the in vitro MRI scans demonstrated the efficiency of 
US-NaGdF4: Tm










Figure 4.25: 2-D spin echo images of US- NaGdF4: Tm
3+, Yb3+  coated with PEG and lysine (a) 
T1 weighted image (b) T2 weighted image. Dilution series identified as 100, 75, 50, 25 % v/v. 
  
   77 
 Chapter Five – Conclusions 
 MRI and optical imaging, the two medical imaging techniques are known to provide 
distinct advantages in disease diagnostics. Upconverting nanoparticles have allowed for the 
design of a magnetic optical hybrid imaging probe, combining high spacial resolution and high 
sensitivity, which could result in images revealing more accurate anatomical information than 
using the two techniques separately. The bimodal contrast agents were designed using two 
different approaches and may have potential application in biological systems.   
The first approach involved the functionalization of a MRI contrast agent, Gd-DOTA 
onto the surface of upconverting nanoparticles NaYF4: Tm
3+, Yb3+ using the click reaction. The 
upconverting nanoparticles NaYF4: Tm
3+ (0.5 mol%), Yb3+ (25 mol%) were synthesized using 
the thermal decomposition procedure. The synthetic conditions were optimized to yield 
monodisperse nanoparticles of size 19.4 ± 2.0 nm. The surface of UCNPs was modified by silica 
coating, which resulted in larger particle size (27.6 ±  3.1 nm), and in water dispersible 
nanoparticles with facile modification of the surface. A multi-step organic procedure was 
followed to synthesize the alkyne_Gd-DOTA, which was conjugated to the azide modified silica 
coated UCNPs using the click reaction. Luminescence spectroscopy measurements of the 
nanoconstruct showed an intense emission of Tm3+ ions at 800 nm, an ideal wavelength for 
bioimaging, upon excitation at 980 nm. The T1 and T2 relaxivities of the nanoconstruct were 
determined to be 16.9 and 28.2 mM-1 s-1 respectively, which were significantly higher than 
commercially available Gd3+ chelates. These results clearly demonstrate the success of 
integrating bi-functionalities to nanoscale materials as a novel contrast agents and optical probe.  
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The second approach involved the design of a bimodal contrast agent to be used as blood 
pool agent. Ultra-small NaGdF4: Tm
3+, Yb3+ of size 5.1 ± 0.5 nm were synthesized. Polymer 
coating using PEG diacid (Mn=600) rendered the hydrophobic nanoparticles water dispersible.  
The PEG capping ligand was confirmed by FTIR and XPS studies. More importantly, the 
polymer coated US-UCNPs showed T1 and T2 relaxivities of 5.79 and 7.41 mM
-1 s-1 respectively, 
which were relatively higher than citrate and lysine capped US-UCNPs. Additionally, PEG 
coated US-UCNPs gave a low zeta potential value of – 4.95 mV at pH 5, which would be 
suitable for in vivo imaging [74]. These nanoparticles provided very good colloidal stability in 
saline solution. Finally, in vitro MRI evaluation showed that the PEG capped ultra-small 
NaGdF4: Tm
3+, Yb3+ can be used as an efficient T1 contrast agent.   
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 Chapter Six – Future Works 
The nanoconstruct Gd-DOTA-NaYF4: Tm
3+, Yb3+ were monodisperse, water dispersible, 
possessed unique optical property and showed high T1 relaxivity as described in the Section 4.2. 
For biological applications, the as-synthesized nanoconstruct must also meet the following 
requirement, the colloidal stability in biological conditions. Preliminary results indicated that the 
as-synthesized Gd-DOTA-UCNPs agglomerated in clinical saline solution. Therefore, it is 
necessary to carry out further surface modification in order to enhance the colloidal system, 
which may be achieved since the silica shell affords itself to a number of reactions for further 
conjugation with a number of molecules.  Since polymer coated nanoparticles was demonstrated 
to provide low surface charge and good colloidal stability in clinical saline, PEG polymer chain 
could be added as a linker between the upconverting nanoparticles and MRI constrast agent Gd-
DOTA. The length of the PEG polymer will need be optimized to obtain monodisperse 
nanoparticles. Figure 6.1 shows the reaction scheme of surface functionalization of Gd-DOTA-
NHS-ester on the surface of polymer-silica coated UCNPs NaYF4: Tm
3+, Yb3+. Amine-PEG 
silane could be simply added to the surface of silica coated nanoparticles through silane 
condensation. The PEG functionalized silica UCNPs will have amine groups on the surface, 
which will allow for the crosslinking reaction with NHS-ester of the Gd complex. This novel 
nanoconstruct is expected to provide good colloidal stability and bimodal imaging capabilities.  
With respect to the PEG coated US-NaGdF4: Tm3+, Yb3+, it would be interesting to carry 
our further studies to evaluate its abilities in providing optical and MR imaging in small animals, 
as well as toxicity and biodistribution.  
 
 








































Figure 6.1: Reaction scheme of surface functionalization of (Gd-DOTA)-PEG polymer on the  
surface of silica coated UCNPs NaYF4: Tm
3+, Yb3+.  
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 Appendix A: Synthesis of Alkyne Gd-DOTA  
8.1 Synthetic scheme for alkyne Gd-DOTA 
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8.2 2-bromo-N-(propargyl)acetamide        
                                                                       (1) 
Yield: 68%  
1H NMR: CDCl3, 500 MHz, 2.28 ppm (t, 1H, J=2.6 Hz, C≡CH), 3.90 (s, 1H, CH2Br), 4.09 (dd, 
2H, J= 2.6, 5.3 Hz, CH2C≡CH), 6.75 (Br, 1H, CONH)       
FTIR: KBr pellet, 3288 cm-1 (N-H stretching), 3251 (–C≡C–H stretching), 2956 (–C–C–H 
stretch), 2126 (C≡C stretching), 1673 (C=O stretching of amide), 1550 (N-H bending), 688 (C-H 
bending of terminal alkyne), 636 (C-Br str.)                                         
Analytical data were in accordance with reported data in the literature [41]. 
     
8.3 Tri-tert-butyl 2, 2̍, 2̍ ̍ - (1,4,7,10-tetraazacyclododecane-1,4,7-triyl) triacetate 
                                                          (2) 
Yield: 71%  
1H NMR: CDCl3 , 500 MHz, 10.26 ppm (br, 1H, NH), 3.37(s, 4H, CH2CO), 3.29 (s, 2H, 
CH2CO), 3.09 (s, 4H, CH2-CH2-NH), 2.88-2.93 (m, 12H, CH2-CH2), 1.46 (s, 27, C(CH3)3) 
FT-IR: KBr pellet, 3401cm-1 (N-H stretching), 2979 (C-H stretching), 1722 (C=O stretching of 
ester), 1592 (N-H bending), 1255 and 1157 (asymmetrical/symmetrical C-O stretching), 1157 
(C-N stretching) 
 Analytical data were in accordance with reported data in the literature [42, 43].  
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8.4 Tri-tert-butyl 2, 2̍, 2̍ ̍ - {10-[2-oxo-2-(2-propyn-1-ylamino)ethyl]-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)} triacetate 
                                                             (3) 
Yield: 66%  
1H NMR: (CD3)2SO , 500 MHz, 8.61 ppm (t, J=5.5 Hz, 1H, CONHCH2), 3.88 (dd, J=2.4, 5.5 
Hz, 2H, CH2C≡CH), 3.31 (s, 8H, CH2CO), 3.08 (t, J=2.4 Hz, 1H, C≡CH), 2.50 (s, 16H,  8xCH2 
cyclen), 1.44 (s, 9H, 3xCH3), 1.43 (s, 18H, 6xCH3) 
13C NMR:  CDCl3, 500 MHz, 172.3 ppm (CO), 171.0 (CO acetamide), 81.9 (C(CH3)3), 81.2 
(C≡CH), 69.2 (C≡CH), 56.0 (NCH2CO), 55.8 (NCH2CONH), 52.1 (br, CH2 cyclen)  
FT-IR: KBr pellet, 3313cm-1 (C-H stretching of C≡CH), 2113 (C≡C stretching), 2979 (C-H 
stretching), 1726 (C=O stretching of ester), 1666 (C=O stretching of amide), 1552 (N-H 
bending), 1160 (asymmetrical/symmetrical C-O asymmetrical/symmetrical), 1101 (C-N 
asymmetrical/symmetrical) 
Analytical data were in accordance with reported data in the literature [42, 43]. 
 
8.5 2, 2̍, 2̍ ̍ - {10-[2-oxo-2-(2-propyn-1-ylamino)ethyl]-1,4,7,10-tetraazacyclododecane-
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Yield: 54%  
1H NMR: (500 MHz, D2O) 3.82 ppm (d, J = 2.2 Hz, 2H, CH2C≡CH), 3.80 (s, 2H, CH2CO), 3.72 
(s, 4H, CH2, CH2CO), 3.53 and 3.54 (2s, 4H, 2xCH2 cyclen), 3.38 (broad, 6H, CH2 cyclen), 3.02 
(broad, 6H, CH2 cyclen), 2.55 (1H, J = 2.5 Hz, 1H, C≡CH ) 
FT-IR: KBr pellet, broad 3149 – 2709 cm-1 (O-H str. of carboxylic acid), 2967 (C-H str.), 1727 
(C=O of carboxylic acid), 1688 (C=O of amide), 1210 (C-O str.). 
Analytical data were in accordance with reported data in the literature [42, 43]. 
 












Yield: 35%  
Purity: >99% 
FT-IR: KBr pellet, 3307 cm-1 (N-H stretching of amide), 2993 (C-H stretching), 2128 (C≡C 
stretching), 1697 and 1404 (asymmetric and symmetric partial C=O stretching of carboxylate), 
1625 (C=O stretching of amide), 1209 (C-O stretching), 1132 (C-N stretching).  
Analytical data were in accordance with reported data in the literature [42, 43]. 
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Figure 8.1: FTIR spectrum of alkyne Gd-DOTA. 
 
The mass spectrometry analysis showing in figure 8.1 strongly confirmed the identity of 
compound (5). The most intense peak at 597.13 m/z observed in the mass spectrum (a) 
corresponded to the atomic mass of compound (5) and the peak at 299.07 corresponded to the 
doubly charged ion of the same compound. In the magnified spectrum (b), scanned from 588 to 
608 m/z, the patterns of the peaks were found to correspond to the percentage of relative 
abundance of gadolinium isotopes. Therefore, this information further confirmed the presence of 











Figure 8.2: Mass spectra of compound (5), alkyne_Gd-DOTA. (a) scanned from 150 -1150 m/z 
(b) a magnified spectrum scanned from 588 to 608 m/z.  
   94 
 Appendix B: Characterization of Lysine Coated US-NaGdF4: Tm3+, Yb3+ 
FT-IR: KBr pellet, 3346 cm-1 (N-H stretching of amine), 2930 (C-H stretching), 1563 and 1427 
(asymmetric and symmetric partial C=O stretching of carboxylate), 1026 (C-O stretching).  
 
 
Figure 9.1: FTIR spectrum of Lysine Coated US- NaGdF4: Tm
3+, Yb3+. 
 
 
